U.S. stock futures traded lower in early pre-market trade. Futures for the Dow Jones Industrial Average dropped 29 points to 27,985 while the Standard & Poor’s 500 index futures fell 2.85 points to 3,143.25. Futures for the Nasdaq 100 index declined 7 points to 8,393.25.
Oil prices traded lower as Brent crude futures fell 1% to trade at $63.74 per barrel, while US WTI crude futures fell 1.1% to trade at $58.558 a barrel.
A Peek Into Global Markets
European markets were lower today, with the Spanish Ibex Index falling 0.1%, STOXX Europe 600 Index declining 0.2% and German DAX 30 index dropping 0.3%. The UK’s FTSE index was trading lower by 0.1%, while French CAC 40 Index fell 0.5%.
In Asian markets, Japan’s Nikkei Stock Average rose 0.33%, Hong Kong’s Hang Seng Index fell 0.01%, China’s Shanghai Composite Index gained 0.08% and India’s BSE Sensex rose 0.10%.
Analysts at SunTrust Robinson Humphrey upgraded Dow Inc. (NYSE: DOW) from Hold to Buy and announced a $59 price target.
Dow shares rose 1.2 percent to $53.83 in pre-market trading.
- ArQule, Inc. (NASDAQ: ARQL) agreed to be acquired by Merck & Co., Inc. (NYSE: MRK) for $20 per share in cash.
- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) disclosed that its Phase 2 trial of KVD001 did not meet its primary endpoint.
- Sanofi SA (NASDAQ: SNY) announced plans to acquire Synthorx Inc (NASDAQ: THOR) in a cash deal worth about $2.5 billion.
- UnitedHealth Group Inc (NYSE: UNH) announced plans to buy Diplomat Pharmacy Inc (NYSE: DPLO) for around $300 million.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.